Abstract
Pulmonary involvement related to acquired immunodeficiency syndrome (AIDS) compromises oxygenation, by both ventilation-perfusion mismatch and increased shunt. In animal studies, meclofenamate, a cyclooxygenase inhibitor, decreases shunt and improves oxygenation. Oral meclofenamate (200 mg) was given to seven patients who had AIDS with pulmonary involvement (Pneumocystis carinii pneumonia or Kaposi’s sarcoma) and abnormal gas exchange.
Arterial Po2 was measured 30 and 0 minutes before and 45 and 60 minutes after administering meclofenamate, and the shunt fraction (venous admixture) was estimated. In all patients, arterial Po2 increased, shunt decreased, and Pco2 and pH did not change after meclofenamate therapy.
Cyclooxygenase inhibition appears to have strengthened hypoxic vasoconstriction and decreased the shunt fraction, possibly by eliminating prostacyclin-induced vasodilation in diseased lung regions. Cyclooxygenase inhibition may be of benefit in the management of hypoxemia associated with AIDS and warrants further investigation.
Deceased.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bakhle YS, Ferreira SH: Lung metabolism of eicosanoids: Prostaglandins, prostacyclin, thromboxane, and leukotrienes, in Handbook of Physiology, Section 3: The Respiratory System. Circulatory and Nonrespiratory Functions. Bethesda, American Physiological Society, 1985, vol 1, pp 365–386.
Garrett RC, Thomas HM 3d: Relation of prostanoids to strength of hypoxic vasoconstriction in dogs with lobar atelectasis. J Appl Physiol 1985; 59:72–77.
Stephenson AH, Sprague RS, Brash DW, et al: Effects of cyclooxygenase inhibition on the renal hemodynamic response to acute hypoxia. Fed Proc 1986; 45:659.
Garrett RC, Thomas HM 3d: Meclofenamate uniformly decreases shunt fraction in dogs with lobar atelectasis. J Appl Physiol 1983; 54:284–289.
Update: Acquired immunodeficiency syndrome (AIDS)—United States. MMWR 1983; 32:389–391.
Snedecor GW, Cochran WG: Statistical Methods. Ames, Iowa, Iowa State University Press, 1973.
Smith G, Cheney FW Jr, Winter PM: The effect of change in cardiac output on intrapulmonary shunting. Br J Anaesth 1974; 46:337–342.
Breen PH, Schumacker PT, Sandoval J, et al: Increased cardiac output increases shunt. Role of pulmonary edema and perfusion. J Appl Physiol 1985; 59:1313–1321.
Hales CA, Rouse ET, Slate JL: Influence of aspirin and indomethacin on variability of alveolar hypoxic vasoconstriction. J Appl Physiol 1978; 45:33–39.
King TK, Weber B, Okinaka A, et al: Oxygen transfer in catastrophic respiratory failure. Chest 1974; 65:40S–44S.
Lamy M, Fallat RJ, Koeniger E, et al: Pathologic features and mechanisms of hypoxemia in adult respiratory distress syndrome. Am Rev Respir Dis 1976; 114:267–284.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Medical Society of the State of New York
About this chapter
Cite this chapter
Foster, S.H., Garrett, R.C., Thomas, H.M. (1989). Cyclooxygenase inhibition and improved oxygenation in patients with pulmonary complications of AIDS. In: Imperato, P.J. (eds) Acquired Immunodeficiency Syndrome. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0807-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0807-2_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8092-7
Online ISBN: 978-1-4613-0807-2
eBook Packages: Springer Book Archive